deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT01978691

The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass (MetSProb)

The Effect of Separate or Combined Supplementation of Probiotic (Bifidobacterium Lactis B420) and Polydextrose on Body Fat Mass

Sponsor: Danisco

Conditions Hyperglycemia Insulin Resistance Obesity
Interventions Bifidobacterium animalis ssp. lactis 420 Placebo Polydextrose
Updated 5 times since 2017 Last updated: Feb 1, 2016 Started: Nov 30, 2013 Primary completion: May 31, 2015 Completion: May 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01978691, this PHASE2 trial focuses on Hyperglycemia and Insulin Resistance and remains completed. Sponsored by Danisco, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Danisco
Data source: Danisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations